Skip to main content
GutCited
Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)
Figure 8. Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)

More Figures from This Paper

Figure 6

Figure 6
Figure 7

Figure 7
Figure 9

Figure 9

Figure 8

1035 × 595px · 180,9 Kio

Source Paper

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal …

Nutrients (2022)

PMID: 36501047

DOI: 10.3390/nu14235017

Cite This Figure

![Figure 8: Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)](https://pdfs.citedhealth.com/figures/36501047/124.png)

> Source: Susie Jung et al. "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of ." *Nutrients*, 2022. PMID: [36501047](https://pubmed.ncbi.nlm.nih.gov/36501047/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/36501047/124.png" alt="Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)" />
  <figcaption>Figure 8. Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)<br>  Source: Susie Jung et al. "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36501047/">36501047</a></figcaption>
</figure>

Preuves associées

B
Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

 D
Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)

Note D · 2 études